Insecticides (India) Limited — Investor Meet, 19-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Insecticides (India) Ltd (IIL) reported Q1 FY'26 revenue up 5% to ₹691 Cr, with EBITDA climbing 122 bps to ₹85 Cr and PAT up 18% to ₹58 Cr. Premium products drove growth, rising 20%, contributing 58% of B2C sales. New launches generated ₹42 Cr in Q1 alone. Management expects sustained EBITDA margin improvement (100 bps annually) and double-digit growth in premium segments. Dahej plant is operational, boosting capacity. New patented products like Altair and SPARCLE are key focus areas. The company's strategy is shifting from generics to high-margin solutions. Q2 sales returns of ₹60-70 Cr are anticipated from Q1 products. Management maintains a confident outlook for profitability and market share.